Zobrazeno 1 - 10
of 206
pro vyhledávání: '"Yang, Zijing"'
In clinical follow-up studies with a time-to-event end point, the difference in the restricted mean survival time (RMST) is a suitable substitute for the hazard ratio (HR). However, the RMST only measures the survival of patients over a period of tim
Externí odkaz:
http://arxiv.org/abs/2306.13949
Autor:
Bechman, Katie, Green, Amelia CA, Russell, Mark D., Yang, Zijing, Zheng, Bang, Norton, Sam, Smith, Rebecca M., Mehrkar, Amir, Bacon, Sebastian C J, Goldacre, Ben, MacKenna, Brian, Galloway, James B
Publikováno v:
In Journal of Infection September 2024 89(3)
Autor:
Yang, Zijing, Li, Yanyan, Lv, You, Hu, Yunfei, Wang, Quanji, Chen, Tianting, Wu, Si, Chen, Qiaodan, Zhang, Xinxin, Deng, Leimin
Publikováno v:
In Journal of Alloys and Compounds 15 August 2024 995
Autor:
Yang, Zijing
This thesis examines the nanoscale morphology evolution during AlN and InN thin film growth. We used synchrotron-based real-time grazing-incidence small-angle X-ray scattering (GISAXS), in order to study the plasma-assisted atomic layer epitaxy (ALEp
Externí odkaz:
https://hdl.handle.net/2144/40709
Inferring the substitutable and complementary products for a given product is an essential and fundamental concern for the recommender system. To achieve this, existing approaches take advantage of the knowledge graphs to learn more evidences for inf
Externí odkaz:
http://arxiv.org/abs/2110.03276
Publikováno v:
In Heliyon 30 May 2024 10(10)
Publikováno v:
In Journal of Materials Research and Technology May-June 2024 30:8529-8538
Publikováno v:
American Journal of Epidemiology, 2021
In clinical and epidemiological studies, hazard ratios are often applied to compare treatment effects between two groups for survival data. For competing risks data, the corresponding quantities of interest are cause-specific hazard ratios (cHRs) and
Externí odkaz:
http://arxiv.org/abs/2106.13390
Publikováno v:
Computer Methods and Programs in Biomedicine. 2021, 207: 106155
In the process of clinical diagnosis and treatment, the restricted mean survival time (RMST), which reflects the life expectancy of patients up to a specified time, can be used as an appropriate outcome measure. However, the RMST only calculates the
Externí odkaz:
http://arxiv.org/abs/2106.10625
Autor:
Yang, Zijing, Hu, Liang, Zhen, Jianxin, Gu, Yuqin, Liu, Yanhong, Huang, Shang, Wei, Yuandan, Zheng, Hao, Guo, Xinxin, Chen, Guo-Bo, Yang, Yan, Xiong, Likuan, Wei, Fengxiang, Liu, Siyang
Publikováno v:
In Blood 11 April 2024 143(15):1528-1538